Tyra Biosciences, Inc.

TYRA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$30-$28-$28-$26
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$6$6$7
Change in WC$0-$1-$3$0
Other Non-Cash$7-$1-$1-$1
Operating Cash Flow-$22-$24-$25-$20
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$65-$20-$7-$38
Inv. Sales/Matur.$50$41$39$45
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$15$21$32$7
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$1$1$2$1
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$1$1$2$1
Forex Effect$0$0$0$0
Net Chg. in Cash-$37-$2$9-$12
Supplemental Information
Beg. Cash$98$102$93$105
End Cash$62$99$102$93
Free Cash Flow-$22-$24-$25-$20